about
The RD114/simian type D retrovirus receptor is a neutral amino acid transporterErythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin CMutations in XPR1 cause primary familial brain calcification associated with altered phosphate exportIntrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates.Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptorResidues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions.Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis.Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot?Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport.Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domainXpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicityHigh-titer packaging cells producing recombinant retroviruses resistant to human serumReceptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein.HTLV-1 tropism and envelope receptor.Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain.Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem Cells.Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters.Receptor-binding domain of murine leukemia virus envelope glycoproteins.A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses.Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement.Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells.Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.XPR1 mutations are a rare cause of primary familial brain calcification.The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis.Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression.[GLUT-1 is the receptor of retrovirus HTLV].Capture in the metabolic arena: co-selection of gamma and deltaretrovirus envelope glycoproteins and their receptors.Mechanism for XMRV neurotoxicity.[Red cell GLUT1 compensates for the lack of vitamin C synthesis in mammals].Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification.[Envelope capture by retroviruses].De l’identification des bases moléculaires des calcifications cérébrales primaires aux mécanismes physiopathologiques : de nouvelles étapesCharacterization of XPR1/SLC53A1 variants located outside of the SPX domain in patients with primary familial brain calcificationInterplay between PFBC-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis
P50
Q22008840-5E9F0C0A-7CE2-44BA-A6CE-B201C5815CB4Q28273605-7EED1B36-3EF9-4490-9233-6A86DB13E6A3Q30397541-70614B4C-7A9F-43E9-8605-3AB42662EC2AQ33244717-BEB1A346-15DB-4B70-9056-1F11D03A8347Q33639579-2847DA13-E5EB-41B9-90BB-379FE385A826Q33780547-CABC799D-DDF4-4C34-B434-4850013D0E36Q33782017-616DD988-86DF-49A4-BDBB-AF380D856E95Q33943870-50202A80-D481-4DD3-BFB7-E7E0B705752EQ34115576-138CCED2-1A10-4E68-8FB4-283EA6391D07Q34437354-C1659B3B-B670-4516-8884-BAB97CB7AA8DQ34464923-5EDDA4C4-B047-4D93-9CCF-D8E5F08D4558Q35689707-CF461CAB-ECEF-4577-82C0-D26AA07077BAQ35851698-AAAA0891-0F4B-42C8-9F68-E00B83A72545Q35863786-4FA2F870-3B7D-4D23-8B68-65ECE132F10BQ36254884-ED33EE50-49E2-4560-BEFB-1E59C678EA5DQ38306674-96961407-3FB1-4DA9-AAB6-7C86066C9022Q38851957-2A4ECAC8-FBDD-48CC-BEC7-62DDD008E20EQ39185528-0C6D727B-B7A4-4423-A929-C30A113F3F9EQ39868615-0B1DC720-5955-4622-B920-881504DBC504Q39958715-397C3129-551B-4520-8E7E-EE0AD8FF2349Q39964229-D474BE29-E41F-4566-A9B9-FA3143527615Q40132706-C6EDBB0F-1CA7-4AEF-B059-4AF4B3F339DCQ40410014-39AEA2BE-9429-49E5-A2B9-E87D0B92B381Q40733370-81DEAA6C-8B72-4A33-AF07-EFB79ABF2611Q43454961-1322B616-426E-4850-B33F-5E0A96F7C9C3Q43720358-0536A60B-7E6B-448C-AD20-B02C04904F71Q44832653-68F214FE-0851-4E18-BAB7-20BA701412E4Q45912839-A669B86D-966C-4925-A094-C09F51FFD690Q46036027-374A3362-60F2-44DA-B8D5-248271C51571Q46649868-06731F14-72DD-4B72-BB0B-57D41C516414Q47858324-E3957FA6-0877-437F-BC99-9FDD9C102237Q55239539-938C598D-572C-49CB-94A6-9658C0FAACFEQ57083844-0D616697-D288-4EC7-B745-6848476DCC3FQ64077224-4B7F850B-4C35-4D3C-806F-21B91D117E9AQ94561157-6788FFAF-DE6E-4C0F-9BB3-3263679224E2
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-5884-9934
@en
name
Jean-Luc Battini
@ast
Jean-Luc Battini
@en
Jean-Luc Battini
@es
Jean-Luc Battini
@nl
type
label
Jean-Luc Battini
@ast
Jean-Luc Battini
@en
Jean-Luc Battini
@es
Jean-Luc Battini
@nl
prefLabel
Jean-Luc Battini
@ast
Jean-Luc Battini
@en
Jean-Luc Battini
@es
Jean-Luc Battini
@nl
P106
P31
P496
0000-0002-5884-9934